1. 334 Baseline demographics and family disease history in patients with atopic dermatitis: an update from the GLOBOSTAD registry. (25th January 2023) Authors: Calzavara-Pinton, Piergiacomo; Čelakovská, Jarmila; Lapeere, Hilde; Holzer, Gregor; Al-Ahmad, Mona; Chu, Chia-Yu; Wu, Jiangming; Ardeleanu, Marius; Bosman, Kwinten Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 7th drug hypersensitivity meeting: part one. Issue 3 (August 2016) Authors: Carr, Daniel; Chung, Wen-Hung; Jenkiins, Rosalind; Chaponda, Mas; Nwikue, Gospel; Cornejo Castro, Elena; Antoine, Daniel; Pirmohamed, Munir; Wuillemin, Natascha; Dina, Dolores; Eriksson, Klara; Yerly, Daniel; Pavlos, Rebecca; Mckinnin, Elizabeth; Ostrov, David; Peters, Bjoern; Buus, Soren; Koelle... Journal: Clinical and translational allergy Issue: Volume 6:Issue 3(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acquired resistance to dabrafenib and trametinib cotreatment in cutaneous melanoma involves endothelin1 (ET-1) and Akt activation. Issue 2 (May 2017) Authors: Chu, Chia-Yu; Sheen, Yi-Shuan; Chen, Yi-Xuan Journal: Journal of dermatological science Issue: Volume 86:Issue 2(2017:May) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dermatologic adverse events associated with afatinib: an oral ErbB family blocker. Issue 6 (June 2013) Authors: Lacouture, Mario E; Schadendorf, Dirk; Chu, Chia-Yu; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Hauschild, Axel Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 6(2013) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dermatologic adverse events associated with afatinib: an oral ErbB family blocker. Issue 6 (June 2013) Authors: Lacouture, Mario E; Schadendorf, Dirk; Chu, Chia-Yu; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Hauschild, Axel Journal: Expert review of anticancer therapy Issue: Volume 13:Issue 6(2013) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epidemiology and comorbidities of patients with chronic urticaria in Taiwan: A nationwide population-based study. Issue 2 (November 2017) Authors: Chu, Chia-Yu; Cho, Yung-Tsu; Jiang, Jhih-Hua; Lin, Eve I-Chun; Tang, Chao-Hsiun Journal: Journal of dermatological science Issue: Volume 88:Issue 2(2017:Nov.) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Esomeprazole-induced Stevens-Johnson syndrome in a patient who underwent nivolumab therapy for advanced lung adenocarcinoma. (October 2020) Authors: Lin, Yi-Tsz; Yang, James Chih-Hsin; Chu, Chia-Yu Journal: Lung cancer Issue: Volume 148(2020) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoid. Issue 1 (July 2016) Authors: Cho, Yung-Tsu; Liao, Shu-Ling; Wang, Li-Fang; Chu, Chia-Yu Journal: Journal of dermatological science Issue: Volume 83:Issue 1(2016:Jul.) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IMP-3 expression predicts unfavorable prognosis in acral lentiginous melanoma. Issue 1 (October 2016) Authors: Sheen, Yi-Shuan; Liao, Yi-Hua; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Chang, Yih-Leong; Chu, Chia-Yu Journal: Journal of dermatological science Issue: Volume 84:Issue 1(2016:Oct.) Page Start: e179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IQGAP1 serves a role on erlotinib-related purpuric dermatitis. Issue 2 (May 2017) Authors: Sheen, Yi-Shuan; Lin, Ming-Hsien; Jou, Tzuu-Shuh; Chu, Chia-Yu Journal: Journal of dermatological science Issue: Volume 86:Issue 2(2017:May) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗